Lexicon Pharmaceuticals, Inc. (LXRX)
2.325
+0.02
(+1.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.325
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Debt to Equity Ratio : 0.3394 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3394 |
| March 31, 2026 | 0.2845 |
| December 31, 2025 | 0.5787 |
| September 30, 2025 | 0.5405 |
| June 30, 2025 | 0.4747 |
| March 31, 2025 | 0.8637 |
| December 31, 2024 | 0.7268 |
| September 30, 2024 | 0.5931 |
| June 30, 2024 | 0.4404 |
| March 31, 2024 | 0.3678 |
| December 31, 2023 | 1.139 |
| September 30, 2023 | 0.7598 |
| June 30, 2023 | 0.5663 |
| March 31, 2023 | 0.6314 |
| December 31, 2022 | 0.4721 |
| September 30, 2022 | 0.2127 |
| June 30, 2022 | 0.3589 |
| March 31, 2022 | 0.2752 |
| December 31, 2021 | 0.0201 |
| September 30, 2021 | 0.104 |
| June 30, 2021 | 0.1044 |
| March 31, 2021 | 0.0944 |
| December 31, 2020 | 0.0819 |
| September 30, 2020 | 0.2382 |
| June 30, 2020 | -23.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 4.495 |
| December 31, 2019 | 2.108 |
| September 30, 2019 | 1.499 |
| June 30, 2019 | -3.806 |
| March 31, 2019 | -5.407 |
| December 31, 2018 | -9.279 |
| September 30, 2018 | -8.331 |
| June 30, 2018 | -48.33 |
| March 31, 2018 | 9.368 |
| December 31, 2017 | 4.715 |
| September 30, 2017 | 1.278 |
| June 30, 2017 | 0.9457 |
| March 31, 2017 | 0.7505 |
| December 31, 2016 | 0.6445 |
| September 30, 2016 | 0.5499 |
| June 30, 2016 | 0.4702 |
| March 31, 2016 | 0.4056 |
| December 31, 2015 | 0.3702 |
| September 30, 2015 | 0.537 |
| June 30, 2015 | 0.4612 |
| March 31, 2015 | 0.4162 |
| December 31, 2014 | 0.3791 |
| September 30, 2014 | 0.2648 |
| June 30, 2014 | 0.1803 |
| March 31, 2014 | 0.1524 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Viatris, Inc. | 0.9555 |
| Pfizer Inc. | 0.7418 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 250.06M |
| Total Liabilities (Quarterly) | 75.54M |
| Shareholders Equity (Quarterly) | 174.52M |
| Current Ratio | 13.37 |
| Net Debt Paydown Yield | 0.88% |